✦ LIBER ✦

Effect of subcutaneous methylnaltrexone on patient-reported outcomes in advanced illness patients with opioid-induced constipation

✍ Scribed by Peppin, J.; Pappagallo, M.; Barrett, A.; Bortey, E.; Paterson, C.; Forbes, W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylnaltrexone Treatment of Opioid-Ind

✍ Bruce H. Chamberlain; Karen Cross; Jaron L. Winston; Jay Thomas; Wenjin Wang; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Efficacy and safety of subcutaneous meth

✍ Nalamachu, S.; Pergolizzi, J.; Taylor, R.; Slatkin, N.; Barrett, A.; Yu, J.; Bor 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Effect of subcutaneous methylnaltrexone

✍ Shrividya S. Iyer; Bruce P. Randazzo; Evan L. Tzanis; Seth L. Schulman; Haiying 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Methylnaltrexone bromide for the treatme

✍ S. R. EARNSHAW; R. M. KLOK; S. IYER; C. MCDADE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 951 KB

Subcutaneous Methylnaltrexone for the Tr

✍ Russell K. Portenoy; Jay Thomas; Michele L. Moehl Boatwright; Diep Tran; Frank L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Subcutaneous methylnaltrexone for the tr

✍ R. Blonsky; E. Michna; S. Schulman; E. Tzanis; A. Manley; H. Zhang; B. Randazzo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB